Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia

We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients and 2707 healthy controls. To increase the likelihood of identifying disease-causing alleles we genotyped 1467 coding nonsynonymous single nuc...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 108; no. 2; pp. 638 - 644
Main Authors Rudd, Matthew F., Sellick, Gabrielle S., Webb, Emily L., Catovsky, Daniel, Houlston, Richard S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.07.2006
Subjects
Online AccessGet full text
ISSN0006-4971
1528-0020
DOI10.1182/blood-2005-12-5022

Cover

Abstract We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients and 2707 healthy controls. To increase the likelihood of identifying disease-causing alleles we genotyped 1467 coding nonsynonymous single nucleotide polymorphisms (nsSNPs) in 865 candidate cancer genes, biasing nsSNP selection toward those predicted to be deleterious. Preeminent associations were identified in SNPs mapping to genes pivotal in the DNA damage-response and cell-cycle pathways, including ATM F858L (odds ratio [OR] = 2.28, P < .0001) and P1054R (OR = 1.68, P = .0006), CHEK2 I157T (OR = 14.83, P = .0008), BRCA2 N372H (OR = 1.45, P = .0032), and BUB1B Q349R (OR = 1.42, P = .0038). Our findings implicate variants in the ATM-BRCA2-CHEK2 DNA damage-response axis with risk of CLL.
AbstractList We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients and 2707 healthy controls. To increase the likelihood of identifying disease-causing alleles we genotyped 1467 coding nonsynonymous single nucleotide polymorphisms (nsSNPs) in 865 candidate cancer genes, biasing nsSNP selection toward those predicted to be deleterious. Preeminent associations were identified in SNPs mapping to genes pivotal in the DNA damage-response and cell-cycle pathways, including ATM F858L (odds ratio [OR] = 2.28, P < .0001) and P1054R (OR = 1.68, P = .0006), CHEK2 I157T (OR = 14.83, P = .0008), BRCA2 N372H (OR = 1.45, P = .0032), and BUB1B Q349R (OR = 1.42, P = .0038). Our findings implicate variants in the ATM-BRCA2-CHEK2 DNA damage-response axis with risk of CLL.
We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients and 2707 healthy controls. To increase the likelihood of identifying disease-causing alleles we genotyped 1467 coding nonsynonymous single nucleotide polymorphisms (nsSNPs) in 865 candidate cancer genes, biasing nsSNP selection toward those predicted to be deleterious. Preeminent associations were identified in SNPs mapping to genes pivotal in the DNA damage-response and cell-cycle pathways, including ATM F858L (odds ratio [OR] = 2.28, P < .0001) and P1054R (OR = 1.68, P = .0006), CHEK2 I157T (OR = 14.83, P = .0008), BRCA2 N372H (OR = 1.45, P = .0032), and BUB1B Q349R (OR = 1.42, P = .0038). Our findings implicate variants in the ATM-BRCA2-CHEK2 DNA damage-response axis with risk of CLL.We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients and 2707 healthy controls. To increase the likelihood of identifying disease-causing alleles we genotyped 1467 coding nonsynonymous single nucleotide polymorphisms (nsSNPs) in 865 candidate cancer genes, biasing nsSNP selection toward those predicted to be deleterious. Preeminent associations were identified in SNPs mapping to genes pivotal in the DNA damage-response and cell-cycle pathways, including ATM F858L (odds ratio [OR] = 2.28, P < .0001) and P1054R (OR = 1.68, P = .0006), CHEK2 I157T (OR = 14.83, P = .0008), BRCA2 N372H (OR = 1.45, P = .0032), and BUB1B Q349R (OR = 1.42, P = .0038). Our findings implicate variants in the ATM-BRCA2-CHEK2 DNA damage-response axis with risk of CLL.
Author Catovsky, Daniel
Sellick, Gabrielle S.
Houlston, Richard S.
Webb, Emily L.
Rudd, Matthew F.
Author_xml – sequence: 1
  givenname: Matthew F.
  surname: Rudd
  fullname: Rudd, Matthew F.
– sequence: 2
  givenname: Gabrielle S.
  surname: Sellick
  fullname: Sellick, Gabrielle S.
– sequence: 3
  givenname: Emily L.
  surname: Webb
  fullname: Webb, Emily L.
– sequence: 4
  givenname: Daniel
  surname: Catovsky
  fullname: Catovsky, Daniel
– sequence: 5
  givenname: Richard S.
  surname: Houlston
  fullname: Houlston, Richard S.
  email: richard.houlston@icr.ac.uk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16574953$$D View this record in MEDLINE/PubMed
BookMark eNp9kMFO3DAQQK0KVBbaH-gB5dSby9hJHEfisl1RqAAhVbRXy5lMtC5JHGxv1f17sl0qJA5II80c3pvDO2YHox-JsU8Cvgih5VnTe99yCVByIXkJUr5jC1FKzQEkHLAFAChe1JU4Yscx_gYQRS7L9-xIqLIq6jJfsLtfNjg7ppi5MUtrypb3t_zrj9VS8tXVxbXM7F8XsylQ6-LkI2XJZ7gOfnSY9dthWnvcpt1NmwcanP3ADjvbR_r4vE_Yz28X96srfnN3-X21vOFYSEg8J9nlFgsUKGqqNEBeN6BVLedVCey6QunKFk2pweq6w1KgghqbTkuF2OYn7PP-7xT844ZiMoOLSH1vR_KbaJRWoOaZwdNncNMM1JopuMGGrfmfYAbkHsDgYwzUvSBgdp3Nv85m19kIaXadZ0m_ktAlm5wfU7Cuf1s936s05_njKJiIjkacCwfCZFrv3tKfADwRlmg
CitedBy_id crossref_primary_10_1002_ijc_29426
crossref_primary_10_1016_j_isci_2024_111620
crossref_primary_10_1111_bjh_17247
crossref_primary_10_1038_s41467_018_05428_6
crossref_primary_10_1002_ajh_21113
crossref_primary_10_1038_s41586_020_2819_2
crossref_primary_10_1016_j_clml_2013_02_002
crossref_primary_10_1016_j_exphem_2011_11_005
crossref_primary_10_1016_j_ebiom_2019_02_011
crossref_primary_10_1097_HS9_0000000000000327
crossref_primary_10_3390_cells10102597
crossref_primary_10_1200_JCO_2007_14_6571
crossref_primary_10_1371_journal_pone_0196512
crossref_primary_10_1210_jc_2013_2165
crossref_primary_10_3816_CLML_2011_n_015
crossref_primary_10_1016_j_hoc_2010_06_001
crossref_primary_10_1186_s13058_021_01484_x
crossref_primary_10_1182_asheducation_2007_1_339
crossref_primary_10_1182_blood_2007_08_110130
crossref_primary_10_1001_jamaoncol_2022_0373
crossref_primary_10_1002_ijc_23212
crossref_primary_10_1038_srep18741
crossref_primary_10_1186_s12967_017_1125_8
crossref_primary_10_1111_j_1365_2141_2008_07355_x
crossref_primary_10_1371_journal_pone_0101685
crossref_primary_10_1016_j_celrep_2022_111869
crossref_primary_10_1002_humu_22939
crossref_primary_10_3390_cancers16040815
crossref_primary_10_1080_10428190701705719
crossref_primary_10_1182_blood_2023019963
crossref_primary_10_1182_bloodadvances_2017015560
crossref_primary_10_1111_j_1365_2141_2007_06810_x
crossref_primary_10_1038_sj_ejhg_5201734
crossref_primary_10_18632_oncotarget_16242
crossref_primary_10_1007_s12156_010_0037_0
crossref_primary_10_1016_j_radonc_2007_04_029
crossref_primary_10_1210_jc_2011_3299
crossref_primary_10_1155_2024_7278636
crossref_primary_10_1111_j_1399_0004_2008_00987_x
crossref_primary_10_1182_blood_2007_07_099432
crossref_primary_10_1182_blood_2008_06_162768
crossref_primary_10_1093_jnci_djn037
crossref_primary_10_1200_JCO_2010_28_9173
crossref_primary_10_1200_PO_20_00387
crossref_primary_10_3389_fonc_2021_740083
crossref_primary_10_1371_journal_pone_0140819
crossref_primary_10_1080_10428190600942462
crossref_primary_10_1146_annurev_pathmechdis_012419_032810
crossref_primary_10_1158_1078_0432_CCR_06_0158
crossref_primary_10_1182_blood_2015_06_652941
crossref_primary_10_1038_nrc2251
crossref_primary_10_1179_102453311X13127324303399
crossref_primary_10_1586_17474086_1_1_51
crossref_primary_10_1038_s41598_017_09604_4
crossref_primary_10_1158_1055_9965_EPI_10_0638
crossref_primary_10_1016_j_yao_2023_01_008
crossref_primary_10_1177_2040620713495639
crossref_primary_10_1186_1471_2407_8_244
crossref_primary_10_3816_CLM_2009_n_004
crossref_primary_10_1002_gcc_22162
crossref_primary_10_1111_j_1365_2141_2008_07281_x
crossref_primary_10_1093_carcin_bgn044
crossref_primary_10_1146_annurev_cancerbio_062822_112257
crossref_primary_10_1186_s13045_017_0443_x
crossref_primary_10_1186_s13053_015_0030_5
crossref_primary_10_1038_leu_2017_201
crossref_primary_10_1038_srep06791
crossref_primary_10_1002_ajh_23184
crossref_primary_10_3389_fgene_2021_652718
crossref_primary_10_3109_10428194_2013_829919
crossref_primary_10_1158_1535_7163_MCT_09_0508
crossref_primary_10_7314_APJCP_2013_14_10_5671
crossref_primary_10_1093_hmg_ddab141
crossref_primary_10_1056_NEJMoa0806122
crossref_primary_10_1111_j_1365_2141_2007_06872_x
crossref_primary_10_1016_j_cell_2007_03_043
crossref_primary_10_1155_2014_370825
crossref_primary_10_1002_gcc_20912
crossref_primary_10_1007_s11899_022_00663_7
crossref_primary_10_1016_j_clml_2016_08_008
crossref_primary_10_1016_j_gene_2018_12_009
crossref_primary_10_1053_j_seminhematol_2013_09_007
crossref_primary_10_1093_hmg_ddm050
crossref_primary_10_1158_0008_5472_CAN_08_2221
crossref_primary_10_3390_cells9122675
crossref_primary_10_1159_000355714
crossref_primary_10_1038_s41431_021_00878_x
crossref_primary_10_1038_ncomms13701
crossref_primary_10_2217_fon_2020_0086
crossref_primary_10_1080_10428194_2020_1737690
crossref_primary_10_1158_1078_0432_CCR_17_0593
crossref_primary_10_2177_jsci_29_136
crossref_primary_10_1200_JCO_22_00269
Cites_doi 10.1093/jnci/86.21.1600
10.1182/blood-2004-01-0341
10.1086/379378
10.1126/science.282.5395.1893
10.1111/j.0006-341X.1999.00997.x
10.1016/S0140-6736(98)10117-4
10.1182/blood.V87.2.423.bloodjournal872423
10.1086/426403
10.1002/gcc.20025
10.1038/75556
10.1002/ijc.10814
10.1038/sj.onc.1202475
10.1002/gcc.10306
10.1093/nar/gkf493
10.1093/hmg/11.12.1399
10.1086/444472
10.1053/j.seminhematol.2004.05.001
10.1093/carcin/21.11.1977
10.1038/sj.bjc.6602007
10.1038/sj.onc.1204811
10.1073/pnas.0407187101
10.1016/S1097-2765(02)00527-0
10.1016/j.ygeno.2003.12.016
10.1093/nar/gkh063
10.1093/nar/gki031
10.1086/319501
10.1101/gr.176601
10.1056/NEJM198705213162101
10.1089/gte.1997.1.165
10.1126/science.273.5281.1516
10.1038/ng1090
10.1038/386804a0
10.1158/1055-9965.EPI-05-0469
10.1038/81691
10.1158/1055-9965.801.13.5
10.1182/blood.V100.2.635
10.1074/jbc.M006190200
10.1093/genetics/138.3.963
10.1038/ng1537
ContentType Journal Article
Copyright 2006 American Society of Hematology
Copyright_xml – notice: 2006 American Society of Hematology
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1182/blood-2005-12-5022
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 644
ExternalDocumentID 16574953
10_1182_blood_2005_12_5022
S0006497120528176
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6I.
6J9
9M8
AAEDW
AAFTH
AAXUO
ABOCM
ABVKL
ACGFO
ADBBV
AENEX
AFFNX
AFOSN
AHPSJ
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
J5H
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
ZGI
0R~
AALRI
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AITUG
AKBMS
AKRWK
AKYEP
AMRAJ
CITATION
H13
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
7X8
EFKBS
ID FETCH-LOGICAL-c420t-3e2f3ac4c1c19e780039b086929b071cff4687a4b580a89fc51c609cbf826ccd3
ISSN 0006-4971
IngestDate Fri Sep 05 13:33:06 EDT 2025
Wed Feb 19 02:30:24 EST 2025
Tue Jul 01 00:54:54 EDT 2025
Thu Apr 24 23:07:29 EDT 2025
Fri Feb 23 02:45:07 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This article is made available under the Elsevier license.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c420t-3e2f3ac4c1c19e780039b086929b071cff4687a4b580a89fc51c609cbf826ccd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://dx.doi.org/10.1182/blood-2005-12-5022
PMID 16574953
PQID 68606606
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_68606606
pubmed_primary_16574953
crossref_primary_10_1182_blood_2005_12_5022
crossref_citationtrail_10_1182_blood_2005_12_5022
elsevier_sciencedirect_doi_10_1182_blood_2005_12_5022
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-07-15
2006-Jul-15
20060715
PublicationDateYYYYMMDD 2006-07-15
PublicationDate_xml – month: 07
  year: 2006
  text: 2006-07-15
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Blood
PublicationTitleAlternate Blood
PublicationYear 2006
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Ng, Henikoff (bib13) 2001; 11
Stankovic, Weber, Stewart (bib25) 1999; 353
Sellick, Webb, Allinson (bib30) 2005; 77
Rawstron, Hillmen, Houlston (bib4) 2004; 41
Marchini, Donnelly, Cardon (bib23) 2005; 37
Goldgar, Easton, Cannon-Albright, Skolnick (bib1) 1994; 86
Auranen, Spurdle, Chen (bib37) 2003; 103
Li, Williams, Haire (bib33) 2002; 9
Cybulski, Gorski, Huzarski (bib34) 2004; 75
Larson, Zhang, Ding (bib27) 1997; 1
Savas, Kim, Ahmad, Shariff, Ozcelik (bib18) 2004; 13
Goldin, Pfeiffer, Li, Hemminki (bib2) 2004; 104
Ford, Ruttan, Kyle, Brackley, Glickman (bib14) 2000; 21
Stephens, Smith, Donnelly (bib21) 2001; 68
Healey, Dunning, Teare (bib36) 2000; 26
Rawstron, Green, Kuzmicki (bib3) 2002; 100
Taylor, Metcalfe, Thick, Mak (bib40) 1996; 87
Gutierrez-Enriquez, Fernet, Dork (bib26) 2004; 40
Xi, Jones, Mohrenweiser (bib24) 2004; 83
Falck, Lukas, Protopopova, Lukas, Selivanova, Bartek (bib32) 2001; 20
Devlin, Roeder (bib19) 1999; 55
Risch, Merikangas (bib5) 1996; 273
Gueven, Keating, Chen (bib39) 2001; 276
Churchill, Doerge (bib20) 1994; 138
Sharan, Morimatsu, Albrecht (bib35) 1997; 386
Rudd, Williams, Webb, Schmidt, Sellick, Houlston (bib8) 2005; 14
Fuks, Milner, Kouzarides (bib38) 1998; 17
Swift, Reitnauer, Morrell, Chase (bib41) 1987; 316
Müller-Hermelink, Catovsky, Harris (bib7) 2001
Maglott, Ostell, Pruitt, Tatusova (bib11) 2005; 33
Ashburner, Ball, Blake (bib9) 2000; 25
Angele, Falconer, Edwards (bib28) 2004; 91
Kanehisa, Goto, Kawashima, Okuno, Hattori (bib10) 2004; 32
Liberzon, Avigad, Stark (bib29) 2004; 39
Matsuoka, Huang, Elledge (bib31) 1998; 282
Ramensky, Bork, Sunyaev (bib12) 2002; 30
Stephens, Donnelly (bib22) 2003; 73
Botstein, Risch (bib6) 2003; 33
2019111904411688800_REF9
2019111904411688800_REF22
2019111904411688800_REF8
2019111904411688800_REF23
2019111904411688800_REF24
2019111904411688800
2019111904411688800_REF25
2019111904411688800_REF26
2019111904411688800_REF27
2019111904411688800_REF28
2019111904411688800_REF29
2019111904411688800_REF40
2019111904411688800_REF41
2019111904411688800_REF20
2019111904411688800_REF21
2019111904411688800_REF19
2019111904411688800_REF11
2019111904411688800_REF33
2019111904411688800_REF12
2019111904411688800_REF34
2019111904411688800_REF13
2019111904411688800_REF35
2019111904411688800_REF14
2019111904411688800_REF36
2019111904411688800_REF37
2019111904411688800_REF38
2019111904411688800_REF39
2019111904411688800_REF18
2019111904411688800_REF30
2019111904411688800_REF31
2019111904411688800_REF10
2019111904411688800_REF32
2019111904411688800_REF1
2019111904411688800_REF3
2019111904411688800_REF2
2019111904411688800_REF5
2019111904411688800_REF4
2019111904411688800_REF7
2019111904411688800_REF6
References_xml – volume: 104
  start-page: 1850
  year: 2004
  end-page: 1854
  ident: bib2
  article-title: Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.
  publication-title: Blood
– volume: 83
  start-page: 970
  year: 2004
  end-page: 979
  ident: bib24
  article-title: Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function.
  publication-title: Genomics
– volume: 25
  start-page: 25
  year: 2000
  end-page: 29
  ident: bib9
  article-title: Gene ontology: tool for the unification of biology: the Gene Ontology Consortium.
  publication-title: Nat Genet
– volume: 32
  start-page: D277
  year: 2004
  end-page: D280
  ident: bib10
  article-title: The KEGG resource for deciphering the genome.
  publication-title: Nucleic Acids Res
– volume: 37
  start-page: 413
  year: 2005
  end-page: 417
  ident: bib23
  article-title: Genome-wide strategies for detecting multiple loci that influence complex diseases.
  publication-title: Nat Genet
– volume: 13
  start-page: 801
  year: 2004
  end-page: 807
  ident: bib18
  article-title: Identifying functional genetic variants in DNA repair pathway using protein conservation analysis.
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 33
  start-page: D54
  year: 2005
  end-page: D58
  ident: bib11
  article-title: Entrez Gene: gene-centered information at NCBI.
  publication-title: Nucleic Acids Res
– volume: 75
  start-page: 1131
  year: 2004
  end-page: 1135
  ident: bib34
  article-title: CHEK2 is a multiorgan cancer susceptibility gene.
  publication-title: Am J Hum Genet
– volume: 26
  start-page: 362
  year: 2000
  end-page: 364
  ident: bib36
  article-title: A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
  publication-title: Nat Genet
– volume: 20
  start-page: 5503
  year: 2001
  end-page: 5510
  ident: bib32
  article-title: Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
  publication-title: Oncogene
– year: 2001
  ident: bib7
  publication-title: Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma
– volume: 55
  start-page: 997
  year: 1999
  end-page: 1004
  ident: bib19
  article-title: Genomic control for association studies.
  publication-title: Biometrics
– volume: 87
  start-page: 423
  year: 1996
  end-page: 438
  ident: bib40
  article-title: Leukemia and lymphoma in ataxia telangiectasia.
  publication-title: Blood
– volume: 282
  start-page: 1893
  year: 1998
  end-page: 1897
  ident: bib31
  article-title: Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.
  publication-title: Science
– volume: 100
  start-page: 635
  year: 2002
  end-page: 639
  ident: bib3
  article-title: Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.
  publication-title: Blood
– volume: 103
  start-page: 427
  year: 2003
  end-page: 430
  ident: bib37
  article-title: BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk.
  publication-title: Int J Cancer
– volume: 9
  start-page: 1045
  year: 2002
  end-page: 1054
  ident: bib33
  article-title: Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2.
  publication-title: Mol Cell
– volume: 73
  start-page: 1162
  year: 2003
  end-page: 1169
  ident: bib22
  article-title: A comparison of bayesian methods for haplotype reconstruction from population genotype data.
  publication-title: Am J Hum Genet
– volume: 316
  start-page: 1289
  year: 1987
  end-page: 1294
  ident: bib41
  article-title: Breast and other cancers in families with ataxia-telangiectasia.
  publication-title: N Engl J Med
– volume: 11
  start-page: 863
  year: 2001
  end-page: 874
  ident: bib13
  article-title: Predicting deleterious amino acid substitutions.
  publication-title: Genome Res
– volume: 276
  start-page: 8884
  year: 2001
  end-page: 8891
  ident: bib39
  article-title: Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasia.
  publication-title: J Biol Chem
– volume: 68
  start-page: 978
  year: 2001
  end-page: 989
  ident: bib21
  article-title: A new statistical method for haplotype reconstruction from population data.
  publication-title: Am J Hum Genet
– volume: 138
  start-page: 963
  year: 1994
  end-page: 971
  ident: bib20
  article-title: Empirical threshold values for quantitative trait mapping.
  publication-title: Genetics
– volume: 39
  start-page: 161
  year: 2004
  end-page: 166
  ident: bib29
  article-title: Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children.
  publication-title: Genes Chromosomes Cancer
– volume: 91
  start-page: 783
  year: 2004
  end-page: 787
  ident: bib28
  article-title: ATM polymorphisms as risk factors for prostate cancer development.
  publication-title: Br J Cancer
– volume: 41
  start-page: 192
  year: 2004
  end-page: 200
  ident: bib4
  article-title: Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients.
  publication-title: Semin Hematol
– volume: 77
  start-page: 420
  year: 2005
  end-page: 429
  ident: bib30
  article-title: A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci.
  publication-title: Am J Hum Genet
– volume: 386
  start-page: 804
  year: 1997
  end-page: 810
  ident: bib35
  article-title: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.
  publication-title: Nature
– volume: 40
  start-page: 109
  year: 2004
  end-page: 119
  ident: bib26
  article-title: Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
  publication-title: Genes Chromosomes Cancer
– volume: 273
  start-page: 1516
  year: 1996
  end-page: 1517
  ident: bib5
  article-title: The future of genetic studies of complex human diseases.
  publication-title: Science
– volume: 1
  start-page: 165
  year: 1997
  end-page: 170
  ident: bib27
  article-title: An allelic variant at the ATM locus is implicated in breast cancer susceptibility.
  publication-title: Genet Test
– volume: 14
  start-page: 2598
  year: 2005
  end-page: 2604
  ident: bib8
  article-title: The predicted impact of coding single nucleotide polymorphisms database.
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 86
  start-page: 1600
  year: 1994
  end-page: 1608
  ident: bib1
  article-title: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
  publication-title: J Natl Cancer Inst
– volume: 17
  start-page: 2531
  year: 1998
  end-page: 2534
  ident: bib38
  article-title: BRCA2 associates with acetyltransferase activity when bound to P/CAF.
  publication-title: Oncogene
– volume: 30
  start-page: 3894
  year: 2002
  end-page: 3900
  ident: bib12
  article-title: Human non-synonymous SNPs: server and survey.
  publication-title: Nucleic Acids Res
– volume: 21
  start-page: 1977
  year: 2000
  end-page: 1981
  ident: bib14
  article-title: Identification of single nucleotide polymorphisms in human DNA repair genes.
  publication-title: Carcinogenesis
– volume: 353
  start-page: 26
  year: 1999
  end-page: 29
  ident: bib25
  article-title: Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.
  publication-title: Lancet
– volume: 33
  start-page: 228
  year: 2003
  end-page: 237
  ident: bib6
  article-title: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease.
  publication-title: Nat Genet
– ident: 2019111904411688800_REF1
  doi: 10.1093/jnci/86.21.1600
– ident: 2019111904411688800_REF2
  doi: 10.1182/blood-2004-01-0341
– ident: 2019111904411688800_REF22
  doi: 10.1086/379378
– ident: 2019111904411688800_REF31
  doi: 10.1126/science.282.5395.1893
– ident: 2019111904411688800_REF19
  doi: 10.1111/j.0006-341X.1999.00997.x
– ident: 2019111904411688800_REF25
  doi: 10.1016/S0140-6736(98)10117-4
– ident: 2019111904411688800_REF40
  doi: 10.1182/blood.V87.2.423.bloodjournal872423
– ident: 2019111904411688800_REF34
  doi: 10.1086/426403
– ident: 2019111904411688800_REF26
  doi: 10.1002/gcc.20025
– ident: 2019111904411688800_REF9
  doi: 10.1038/75556
– ident: 2019111904411688800_REF37
  doi: 10.1002/ijc.10814
– ident: 2019111904411688800_REF38
  doi: 10.1038/sj.onc.1202475
– ident: 2019111904411688800_REF29
  doi: 10.1002/gcc.10306
– ident: 2019111904411688800_REF12
  doi: 10.1093/nar/gkf493
– ident: 2019111904411688800_
  doi: 10.1093/hmg/11.12.1399
– ident: 2019111904411688800_
– ident: 2019111904411688800_REF30
  doi: 10.1086/444472
– ident: 2019111904411688800_REF4
  doi: 10.1053/j.seminhematol.2004.05.001
– ident: 2019111904411688800_REF14
  doi: 10.1093/carcin/21.11.1977
– ident: 2019111904411688800_REF28
  doi: 10.1038/sj.bjc.6602007
– ident: 2019111904411688800_REF32
  doi: 10.1038/sj.onc.1204811
– ident: 2019111904411688800_
  doi: 10.1073/pnas.0407187101
– ident: 2019111904411688800_REF33
  doi: 10.1016/S1097-2765(02)00527-0
– ident: 2019111904411688800_REF24
  doi: 10.1016/j.ygeno.2003.12.016
– ident: 2019111904411688800_REF10
  doi: 10.1093/nar/gkh063
– ident: 2019111904411688800_REF11
  doi: 10.1093/nar/gki031
– ident: 2019111904411688800_REF21
  doi: 10.1086/319501
– ident: 2019111904411688800_REF13
  doi: 10.1101/gr.176601
– ident: 2019111904411688800_REF41
  doi: 10.1056/NEJM198705213162101
– ident: 2019111904411688800_REF27
  doi: 10.1089/gte.1997.1.165
– ident: 2019111904411688800_REF5
  doi: 10.1126/science.273.5281.1516
– ident: 2019111904411688800_REF6
  doi: 10.1038/ng1090
– ident: 2019111904411688800_REF35
  doi: 10.1038/386804a0
– ident: 2019111904411688800_REF8
  doi: 10.1158/1055-9965.EPI-05-0469
– ident: 2019111904411688800_REF36
  doi: 10.1038/81691
– ident: 2019111904411688800_REF7
– ident: 2019111904411688800_REF18
  doi: 10.1158/1055-9965.801.13.5
– ident: 2019111904411688800_REF3
  doi: 10.1182/blood.V100.2.635
– ident: 2019111904411688800_REF39
  doi: 10.1074/jbc.M006190200
– ident: 2019111904411688800_REF20
  doi: 10.1093/genetics/138.3.963
– ident: 2019111904411688800_REF23
  doi: 10.1038/ng1537
SSID ssj0014325
Score 2.211561
Snippet We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 638
SubjectTerms Aged
Ataxia Telangiectasia Mutated Proteins
BRCA2 Protein - genetics
Case-Control Studies
Cell Cycle - genetics
Cell Cycle Proteins - genetics
Checkpoint Kinase 2
DNA Damage - genetics
DNA Repair - genetics
DNA-Binding Proteins - genetics
Female
Genetic Predisposition to Disease
Genotype
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - etiology
Leukemia, Lymphocytic, Chronic, B-Cell - genetics
Male
Middle Aged
Polymorphism, Single Nucleotide - genetics
Polymorphism, Single Nucleotide - physiology
Protein-Serine-Threonine Kinases - genetics
Tumor Suppressor Proteins - genetics
Title Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia
URI https://dx.doi.org/10.1182/blood-2005-12-5022
https://www.ncbi.nlm.nih.gov/pubmed/16574953
https://www.proquest.com/docview/68606606
Volume 108
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgCMYLgo5LufoB8VIFEttxkscu6qhg3QRKUd8sx3GkiiydWIoov57jOGnajo3LixVFcRvlO7bO53P5EHrNZe5RRpTDNEthkIETaSArXGaE0ijz_NAUCk9O-HjKPsz8WSf8V1eXVOlb9fO3dSX_gyrcA1xNlew_ILv-UbgB14AvjIAwjH-F8RcgunUeS5OsOEwmzuHneEiceDz6SAbyx_zCdAHI5iY5qxbJULYZ7qBYAYwLtTL9Wgu9_KrP5nIrwFs0KvI2DT6z2sNWHHwjG9i087Qb6nuZAusuTGribrRnVJ-hrE-ZY-D535szW1vhvnv0EDi2-HK9nXIjUedtbaduuGE3ZGNz5LaPy-VNOzRNYG2ivu2MCvzYteXK2x2yT07F0fT4WCSjWXIT3SIB-EsmEP-pixwxSqxqRfNqbaFUSN5d_oernJGryEbtdCT30b2GLeChhf4BuqHLHjoYlvAFz1b4Da7zd-vASA_dPmyv9uNWxa-H7kya5IkDdNqaC56XGHDEO-aCjbngzlxwtcCNueANc8GtuTxE06NREo-dRk_DUYy4lUM1yalUTHnKMwvS1GWnQGnBQ07B01R5zngYSJb6oSvDKFe-p7gbqTQHDqpURh-hvXJR6icIU1j6EeVKU-ozlfEI_Frw_nItAROXqD7y2g8rVNNs3mieFKImnSERNRhGBNUXHhEGjD4arOec21Yr1z7tt3iJxlm0TqAAs7p23qsWXAFQmPCYLPVieSF4aMi8y_voscW8ewvuByYP--kf5z5Dd7uF8hztVd-W-gV4rVX6sjbTX4Jak5U
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Variants+in+the+ATM-BRCA2-CHEK2+axis+predispose+to+chronic+lymphocytic+leukemia&rft.jtitle=Blood&rft.au=Rudd%2C+Matthew+F&rft.au=Sellick%2C+Gabrielle+S&rft.au=Webb%2C+Emily+L&rft.au=Catovsky%2C+Daniel&rft.date=2006-07-15&rft.issn=0006-4971&rft.volume=108&rft.issue=2&rft.spage=638&rft_id=info:doi/10.1182%2Fblood-2005-12-5022&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon